Evidence for cholinergic vagal afferents and vagal presynaptic M1 receptors in the ferret.
The distribution of muscarinic receptor binding was examined in the ferret brainstem vagal nuclei using the non-selective ligand [3H]quinuclidinyl benzilate and the relatively M1 receptor-selective ligand [3H]pirenzepine. The highest density of receptor sites are found in the subnucleus gelatinosus and lower levels in the other subnuclei of the nucleus of the tractus solitarius and in the area postrema and dorsal motor nucleus of the vagus nerve. Dense binding was also seen in the adjacent hypoglossal nucleus. Following unilateral cervical nodose ganglion excision binding in the subnucleus gelatinosus was attenuated ipsilateral to the lesion compared with the contralateral side. In contrast, [3H]pirenzepine binding was only seen in the subnucleus gelatinosus and in no other region at this level of the brainstem. This binding was reduced in the subnucleus as a whole by 52% ipsilateral to a cervical vagotomy. In the more rostral parts of the subnucleus gelatinosus, binding was undetectable ipsilateral to the lesion but more caudally, appreciable levels of binding persisted. This distribution parallels the known rostro-caudal variation in cross-over of vagal afferent fibres in the ferret dorsal vagal complex and indicates a presynaptic localization of [3H]pirenzepine binding sites on vagal afferent terminals. The distribution of binding of the high affinity choline uptake site blocker, [3H]hemicholinium-3, was also examined in the ferret brainstem using autoradiography. High densities of [3H]hemicholinium-3 binding were seen in the hypoglossal nucleus, the subnucleus gelatinosus and in the area postrema, with lower levels in the dorsal motor nucleus of the vagus, the trigeminal nucleus and other subnuclei of the nucleus of the tractus solitarius.(ABSTRACT TRUNCATED AT 250 WORDS)
University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford.
D J
DJ
Reynolds
P R
PR
Lowenstein
J M
JM
Moorman
D G
DG
Grahame-Smith
R A
RA
Leslie
D000818:Animals; D001345:Autoradiography; D001665:Binding Sites; D001933:Brain Stem / Q000033:anatomy & histology / Q000378:metabolism*; D003391:Cranial Nerves / Q000033:anatomy & histology; D005289:Ferrets; D006426:Hemicholinium 3; D066298:In Vitro Techniques; D008526:Medulla Oblongata / Q000033:anatomy & histology / Q000378:metabolism*; D010890:Pirenzepine / Q000032:analysis*; D011813:Quinuclidinyl Benzilate / Q000032:analysis*; D011950:Receptors, Cholinergic / Q000032:analysis*; D011976:Receptors, Muscarinic / Q000032:analysis*
D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D006426:Hemicholinium 3; D010890:Pirenzepine; D011813:Quinuclidinyl Benzilate